Variable | Size < 1 (n = 32) | 1 < = size < 5 (n = 69) | Size > = 5 (n = 55) | P-value | Corrected P-value | Spearman Correlation |
---|---|---|---|---|---|---|
Gender | ||||||
Male | 10 (31.2%) | 21 (29.4%) | 26 (47.3%) | 0.190 | 0.342 | |
Female | 22 (68.8%) | 48 (70.6%) | 29 (52.7%) | |||
Race | ||||||
White | 1 (3.1%) | 7 (10.1%) | 6 (10.9%) | 0.066 | 0.239 | |
Black | 9 (28.1%) | 19 (27.5%) | 21 (38.2%) | |||
Other | 22 (68.8%) | 43 (62.3%) | 28 (50.9%) | |||
Age | ||||||
Median | 47 | 52.5 | 62 | < 0.001 | < 0.001 | 0.35 (0.2–0.48) |
IQR | 31.8–57.8 | 35.8–63.5 | 53–75.5 | |||
Diabetes | 9 (28.1%) | 18 (26.5%) | 20 (36.4%) | 0.274 | 0.411 | |
Systemic Immunosuppression | 5 (15.6%) | 12 (17.6%) | 16 (29.1%) | 0.088 | 0.245 | |
Ocular Surface Disease | 13 (40.6%) | 24 (34.8%) | 29 (52.7%) | 0.118 | 0.245 | |
Previous Eye Surgery | 5 (15.6%) | 16 (23.5%) | 14 (25.5%) | 0.358 | 0.473 | |
History of Trauma | 6 (19.4%) | 9 (13%) | 6 (11.1%) | 0.417 | 0.501 | |
Inappropriate Contact Lens Use | 11 (84.6%) | 16 (64%) | 13 (76.5%) | 0.516 | 0.516 | |
Steroid Eye Drop Use (Local Immunosuppression) | 4 (12.5%) | 14 (20.6) | 14 (25.5%) | 0.122 | 0.245 | |
Corneal Ulcer Location | ||||||
Central | 15 (41.4%) | 25 (35.3%) | 39 (69.2%) | < 0.001 | < 0.001 | |
Peripheral | 17 (58.6%) | 44 (64.7%) | 16 (30.8%) | |||
Patient Reported Start of Symptomsa | ||||||
Median | 2.5 | 3 | 3 | 0.249 | 0.408 | 0.1 (-0.07–0.26) |
IQR | 1–4 | 1.8–6.2 | 1–7 | |||
Log MAR (at presentation) | ||||||
Median | 0.3 | 0.5 | 1.9 | < 0.001 | < 0.001 | 0.55 (0.43–0.65) |
IQR | 0.1–0.5 | 0.3–1.9 | 1.1–2.3 | |||
Among Patients with Cultured Result (n = 108) | n = 17 | n = 39 | n = 52 | |||
Positive Culture | 12 (70.6%) | 25 (64.1%) | 38 (73.1%) | 0.469 | 0.516 | |
Gram- Positive Cocci Presence | 11 (64.7%) | 19 (48.7%) | 25 (48.1%) | 0.368 | 0.473 | |
Gram-Negative Rod Presence | 0 (0%) | 6 (15.4%) | 20 (38.5%) | < 0.001 | < 0.001 | |
Gram-Positive Rod Presence | 1 (5.9%) | 1 (2.6%) | 3 (5.8%) | 0.492 | 0.516 | |
Fungi Presence | 0 (0%) | 1 (2.6%) | 3 (5.8%) | 0.112 | 0.245 |